There is a struggle right now to push the World Trade Organization to waive patent protections for medicines, vaccines and technology used for the COVID-19 pandemic. James Love of Knowledge Ecology International explains why that would be an important but not sufficient step to increase access to medicines and vaccines. There are steps governments could take right now to share critical information and expertise to lessen the disparities between rich and poor nations in access to vaccines. Love goes on to explain how there could be greater openness in sharing information in general and how pharmaceutical research and production could be done in ways that improve innovation and make access more equitable. He points the way to where activists can best focus their energy on this issue.
James Love is Director of Knowledge Ecology International. His training is in economics and finance, and work focuses on the production, management and access to knowledge resources, as well as aspects of competition policy. The current focus is on the financing of research and development, intellectual property rights, prices for and access to new drugs, vaccines and other medical technologies, as well as related topics for other knowledge goods, including data, software, other information protected by copyright or related rights, and proposals to expand the production of knowledge as a public good. James Love holds a Masters of Public Administration from Harvard University’s Kennedy School of Government and a Masters in Public Affairs from Princeton’s Woodrow Wilson School of Public and International Affairs.